Mutation count, a potential surrogate for tumor mutation load, of circulating tumor DNA (ctDNA) using targeted panel sequencing correlates with clinical outcomes in late stage lung adenocarcinoma and small cell lung cancer.
2018 ◽
Vol 36
(15_suppl)
◽
pp. 12045-12045
Keyword(s):
Keyword(s):
2018 ◽
Vol 102
(3)
◽
pp. e676
Keyword(s):
2022 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 12
(9)
◽
pp. 1376-1387
◽
Keyword(s):